Discovery of novel anti-Toxoplasma gondii agent derived from thiazolidinone-isatin hybrids: synthesis, biological assessment, and computational modeling
Abstract
Toxoplasmosis is a globally prevalent parasitic infection that disproportionately impacts immunocompromised individuals and remains a significant public health challenge. The limitations of current standard-of-care therapies, marked by severe adverse effects and an inability to eradicate persistent cysts, necessitate the urgent development of novel, safer, and more efficacious anti-Toxoplasma agents. Employing a rational molecular hybridization strategy, we designed and synthesized a novel series of seventeen thiazolidinone-isatin hybrid derivatives to evaluate their in vitro inhibitory effects against the Toxoplasma gondii RH strain. The phenotypic screening revealed that most of the synthesized hybrids exhibited significant antiparasitic activity, with compounds 4a, 7g, and 7j emerging as highly promising leads. Notably, the unsubstituted isatin derivative 4a was the most potent agent of the series (IC50 = 0.21 µg mL-1). Crucially, 4a exhibited an exceptional safety profile and a remarkably broad therapeutic window, achieving a selectivity index (SI) in Hs27 host cells of >1171, vastly outperforming pyrimethamine, sulfadiazine and trimethoprim. Subsequent mechanistic assays confirmed that 4a profoundly impedes the intracellular proliferation of T. gondii tachyzoites in a rapid, dose-dependent manner. In order to elucidate the putative mechanism of action at the molecular level, comprehensive in silico investigations were conducted. In silico molecular docking and 100 ns…
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.